Table 2.

Main effects and two-way interactions of baseline and demographic variables on wellbeing across time in OA. f: female; SE: Standard Error.

Term	B	SE	t-value	p
Intercept	19.28	17.99	1.071	.28
2-week endpoint	9.77	18.42	0.530	.60
4-week endpoint	15.74	16.39	0.960	.34
Age	0.39	0.26	1.502	.14
Gender (f)	−1.44	2.12	−0.681	.50
Psychedelic use	0.61	0.67	0.914	.36
Psychiatric history	−3.00	2.45	1.207	.23
Expectations	.01	.06	0.258	.80
Age:2-week endpoint	0.00	0.27	−0.016	.99
Age:4-week endpoint	−0.17	0.23	−0.734	.47
Gender (f):2-week endpoint	−0.82	2.21	−0.373	.71
Gender (f):4-week endpoint	2.46	1.96	1.259	.21
Psychedelic use:2-week endpoint	−0.70	0.65	−1.083	.28
Psychedelic use:4-week endpoint	0.06	0.57	0.097	.92
Psychiatric history:2-week endpoint	−6.62	2.77	−2.388	.02
Psychiatric history:4-week endpoint	−5.69	2.32	−2.457	.02
Expectations:2-week endpoint	0.02	0.06	0.403	.69
Expectations:4-week endpoint	0.02	0.05	0.4000	.69